External experts are sought after advisors for life science companies, where they make informed critical decisions along the entire product lifecycle of a drug.
These experts use the knowledge and experience they acquired over the course of their careers to help companies address challenges like identifying unmet medical needs, clinical trial design, stratification of patient populations, label extensions, product positioning, regulatory challenges, and many others.
They can also serve as the scientific face of the organization, e.g., by discussing trial results during conferences and/or co-authoring scientific publications.
Traditionally, these external experts have been referred to as “opinion leaders”, or “key opinion leaders” (KOLs) and recognized thanks to their proven expertise and scientific exposure in activities such as publications or speaking at relevant conferences.
The purpose of this training is defining a list of objective and measurable criteria to be used for KOLs' mapping, regardless the therapeutic area, to support pharma & biotech medical professionals in creating a network of experts with whom establish a trustful, durable and fruitful collaboration.